Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care

Vries, V.A. de; Muller, M.C.A.; Arbous, M.S.; Biemond, B.J.; Blijlevens, N.M.A.; Kusadasi, N.; ... ; HEMA-ICU Study Grp (2019)

Article / Letter to editor

• hematologic malignancy
• intensive care unit
• multiple organ failure/mortality
• organ failure
• prognosis

• All authors: Vries, V.A. de; Muller, M.C.A.; Arbous, M.S.; Biemond, B.J.; Blijlevens, N.M.A.; Kusadasi, N.; Span, L.R.F.; Vlaar, A.P.J.; Westerloo, D.J. van; Kluin-Nelemans, H.C.; Bergh, W.M. van den; Tuinman, P.R.; Spoelstra, A.; Marijt, E.; Blijlevens, N.; Hilkens, M.; Epker, J.; Broers, A.; Choi, G.; Demandt, A.; Mook, W. van; HEMA-ICU Study Grp
• Date: 2019-02-28
• Journal: Critical Care Medicine
• Volume: 47
• Issue: 2
• Pages: E120 - E128
• DOI: doi:10.1097/CCM.0000000000003526